155 0

Full metadata record

DC FieldValueLanguage
dc.contributor.author최한곤-
dc.date.accessioned2019-03-08T02:41:44Z-
dc.date.available2019-03-08T02:41:44Z-
dc.date.issued2015-01-
dc.identifier.citationJOURNAL OF MATERIALS CHEMISTRY B, v. 3, No. 3, Page. 408-416en_US
dc.identifier.issn2050-750X-
dc.identifier.issn2050-7518-
dc.identifier.urihttp://pubs.rsc.org/-/content/articlehtml/2015/tb/c4tb01442a-
dc.identifier.urihttps://repository.hanyang.ac.kr/handle/20.500.11754/100622-
dc.description.abstractAxitinib (AXT) is a potent and selective orally administered inhibitor of the vascular endothelial growth factor receptors 1-3 that contribute to the pathogenesis of solid tumors. The goal of the present study was to enhance the antiangiogenic and antitumor effects of AXT under hypoxia. Here we developed spherical polypeptide-coated hybrid liposomal nanoparticles (P-LNP/AXT) with a narrow size distribution and high loading efficiency. The cytotoxic effects of P-LNP/AXT on cancer cells were lower than those of AXT, and the human cancer cell lines SCC7, BT-474, and SH-SY5YP efficiently incorporated P-LNP/AXT. However, these formulations were not significantly internalized by the mouse macrophage cell line RAW 264.7, suggesting that they could evade the reticuloendothelial system. Western blotting analysis showed a significant increase in the level of expression of hydroxy-HIF-1 alpha when cells were treated with P-LNP/ AXT. The growth of tumors in mice treated with P-LNP/AXT was significantly inhibited compared with controls. Further, elevated levels of caspase-3 and poly (ADP-ribose) polymerase and reduced levels of platelet/endothelial cell adhesion molecule 1 (PECAM1, CD31) and Ki-67 in tumor cells suggested that tumor cells underwent apoptosis and that angiogenesis was inhibited within the tumor. Thus, P-LNP/AXT shows promise for cancer chemotherapy by inhibiting tumor angiogenesis.en_US
dc.description.sponsorshipThis research was supported by a National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (no. 2012R1A2A2A02044997 and no. 2012R1A1A1039059).en_US
dc.language.isoen_USen_US
dc.publisherROYAL SOC CHEMISTRYen_US
dc.subjectSTERICALLY STABILIZED LIPOSOMESen_US
dc.subjectCHITOSAN NANOPARTICLESen_US
dc.subjectPOLYETHYLENE-GLYCOLen_US
dc.subjectCOMPLEX MICELLESen_US
dc.subjectDRUG-DELIVERYen_US
dc.subjectCANCERen_US
dc.subjectHIF-1en_US
dc.subjectDOXORUBICINen_US
dc.subjectTHERAPYen_US
dc.subjectTARGETen_US
dc.titleSystemic delivery of axitinib with nanohybrid liposomal nanoparticles inhibits hypoxic tumor growthen_US
dc.typeArticleen_US
dc.relation.no3-
dc.relation.volume3-
dc.identifier.doi10.1039/c4tb01442a-
dc.relation.page408-416-
dc.relation.journalJOURNAL OF MATERIALS CHEMISTRY B-
dc.contributor.googleauthorChoi, JY-
dc.contributor.googleauthorRamasamy, T-
dc.contributor.googleauthorTran, TH-
dc.contributor.googleauthorKu, SK-
dc.contributor.googleauthorShin, BS-
dc.contributor.googleauthorChoi, HG-
dc.contributor.googleauthorYong, CS-
dc.contributor.googleauthorKim, JO-
dc.relation.code2015002630-
dc.sector.campusE-
dc.sector.daehakCOLLEGE OF PHARMACY[E]-
dc.sector.departmentDEPARTMENT OF PHARMACY-
dc.identifier.pidhangon-
Appears in Collections:
COLLEGE OF PHARMACY[E](약학대학) > PHARMACY(약학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE